Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Variations of Cognitive Behavior Therapy for Social Anxiety Disorder

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
James Herbert, Drexel University
ClinicalTrials.gov Identifier:
NCT00948974
First received: July 29, 2009
Last updated: January 21, 2016
Last verified: January 2016

July 29, 2009
January 21, 2016
January 2010
January 2015   (Final data collection date for primary outcome measure)
Social Phobia and Anxiety Inventory [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Social Phobia and Anxiety Scale [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Social Anxiety Scale [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Beck Depression Inventory [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Beck Anxiety Inventory [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Quality of Life Inventory [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Outcomes Questionnaire [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Brief Fear of Negative Evaluation Scale [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Sheehan Disability Scale [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Clinical Global Impression Scale [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Client Satisfaction Survey [ Time Frame: Post-Treatment ]
  • Behavioral Assessment Test [ Time Frame: Pre-treatment, Post-treatment ]
  • Five Factor Mindfulness Questionnaire [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
Complete list of historical versions of study NCT00948974 on ClinicalTrials.gov Archive Site
  • Philadelphia Mindfulness Scale (PHLMS) [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Outcomes Questionnaire [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3-month followup ]
  • Behavioral Assessment Test [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3-month, 12-month follow-up ]
  • Quality of Life Inventory [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Drexel Defusion Scale (DDS) [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Philadelphia Mindfulness Scale (PHLMS) [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Automatic Thoughts Questionnaire (ATQ) [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Before-Session Questionnaire (BSQ) [ Time Frame: weekly ]
  • Reaction to Treatment Questionnaire (RTQ) [ Time Frame: After 2nd session ]
  • Experiences Questionnaire [ Time Frame: pre-treatment, mid-treatment, post-treatment, 3 month followup, 12 month followup ]
  • Social Anxiety Session Change Index [ Time Frame: weekly ]
Not Provided
Not Provided
 
Variations of Cognitive Behavior Therapy for Social Anxiety Disorder
Variations of Cognitive Behavior Therapy for Social Anxiety Disorder
The purpose of this study is to compare the efficacy of two variants of cognitive behavioral therapy (CBT) (cognitive therapy (CT) and acceptance and commitment therapy (ACT)), for the treatment of generalized social anxiety disorder.
We are recruiting a clinical sample of patients who meet diagnostic criteria (per DSM-5) for the generalized subtype of social anxiety disorder. Participants are randomly assigned to the two active intervention conditions; no placebo or sham treatments will be employed. Assessments take place at baseline, pre-treatment, mid-treatment, post-treatment, and at 3- and 12-months follow-up; participants also complete a brief weekly assessment of functioning. Treatment is administered individually by trained graduate students in clinical psychology, directly trained and supervised by the PI and Co-PI. Participants receive 12 weekly 1-hour long sessions. The study design is a 2 (treatment condition) by 5 (assessment occasion) mixed factorial design.
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Social Anxiety Disorder
  • Behavioral: Cognitive Therapy
    Cognitive therapy (CT) highlights the identification and reappraisal of distorted or dysfunctional cognitions in the treatment of psychopathology. For example, socially anxious patients are taught to identify the thoughts and underlying beliefs that trigger strong emotional reactions (e.g., "if I attempt to initiate a conversation I'll humiliate myself"), and then replace these with more accurate, functional thoughts. There is a large body of research supporting the efficacy of CT for mood and anxiety disorders, and for social anxiety disorder in particular (Beck, 2005).
    Other Name: CT
  • Behavioral: Acceptance and Commitment Therapy
    ACT does not attempt to modify cognitions directly, but rather seeks to foster a mindful acceptance of whatever thoughts or feelings arise, while still pursuing specific behavioral goals. For example, the individual would be taught simply to notice the thoughts as if from a distance without attempting to modify them, and initiate a conversation. Like other newer mindfulness and acceptance-based models of CBT, ACT also expands the traditional focus on symptom reduction to include an emphasis on broader life goals. The scientific literature on ACT has expanded rapidly over the past ten years. Recent reviews conclude that it appears to be at least as effective as CT, and may work at least in part via distinct treatment mechanisms (Powers, Zum Vörde Sive Vörding, & Emmelkamp, 2009).
    Other Name: ACT
  • Active Comparator: cognitive therapy
    cognitive therapy and exposure
    Intervention: Behavioral: Cognitive Therapy
  • Active Comparator: acceptance and committment therapy
    acceptance and commitment therapy and exposure
    Intervention: Behavioral: Acceptance and Commitment Therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
132
December 2015
January 2015   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Clinically diagnosable social anxiety disorder (generalized subtype per DSM-IV-TR criteria)
  • aged 18-65
  • working fluency in English
  • residence in the greater Philadelphia area.

Exclusion Criteria:

  • Pervasive developmental disability
  • acute suicide potential
  • inability to travel to the treatment site
  • schizophrenia or other psychotic disorder
  • current substance dependence
  • Comorbid diagnoses of Major Depressive or other mood or anxiety disorders are acceptable ONLY if clearly secondary to the diagnosis of social anxiety disorder.
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00948974
18345
No
Not Provided
Not Provided
Not Provided
James Herbert, Drexel University
Drexel University
Not Provided
Principal Investigator: James D. Herbert, PhD Drexel University
Drexel University
January 2016

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP